Document:

Exhibit 10.29 Marketing Agreement

    
      

    

     

                                                                                                    Exhibit
      10.29

     

    
 

    MARKETING
      AGREEMENT

     

    This
      document, dated November 14, 2006, shall serve as the Agreement between Atlantic
      Television Marketing, Inc. (Atlantic) and Genotec Nutritionals, Inc. (Genotec)
      regarding Atlantic’s services for the marketing of the Sugarest nutritional
      product (hereinafter referred to as the Product).

     

    SERVICES

     

    Atlantic’s
      services will include:

     

    ·  PROJECT
      MANAGEMENT.
      Genotec
      hereby engages Atlantic to develop and manage the marketing campaign for the
      Product including but not limited to the management of the development of a
      web
      site for Product sales, management of a press and publicity campaign to
      publicize the Product through news media, and set up and management of back
      end
      services such as telemarketing and fulfillment.

     

    ·  DEVELOPMENT
      OF WEB SITE.
      Genotec
      hereby engages Atlantic to manage the creation and establishment of a commerce
      web site for the Product including selection and management of a web development
      agency, and management and development of any additional marketing elements
      needed for the web site. It is understood that the web development agency will
      charge direct development fees and/or on-going operational fees and those fees
      will be charged directly to Genotec by the service provider.

     

    ·  IMPLEMENTATION
      OF MEDIA CAMPAIGN.
      Genotec
      hereby engages Atlantic to manage and implement a media campaign, including
      selection and set-up of a publicity agency and other news and information
      distribution agencies. It is understood that the agencies will charge direct
      development fees and/or operational fees and those fees will be charged directly
      to Genotec by the service provider.

     

    ·  SET
      UP
      OF BACKEND OPERATIONS.
      Genotec
      hereby engages Atlantic to establish and set-up the back-end operational
      elements of the campaign, including selection and set-up of a telemarketing
      agency, selection and set-up of a fulfillment company, and set-up of the
      additional necessary operational elements of a direct marketing campaign. It
      is
      understood that the service providers will charge direct set-up fees and/or
      operational fees and those fees will be charged directly to Genotec by the
      service providers.

     

    ·  BACKEND
      OPERATIONAL MANAGEMENT.
      Genotec
      hereby engages Atlantic to manage the operational elements of the on-going
      campaign including: supervision of the media campaign, analysis of the sales
      results, management of the telemarketing agency, management of the fulfillment
      company, and on-going management of the direct sales processing operations.
      It
      is understood that the service providers will charge on-going operational fees
      and those fees will be charged directly to Genotec by the service
      providers.

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

     

    COMPENSATION

     

    As
      compensation for these services, Genotec shall pay to Atlantic a fee of
      $10,500.00 per month. Atlantic shall receive $7,500.00 per month in cash and
      $3,000.00 per month in MM2 Group, Inc. stock (OTCBB: MMGP) issued at a 20%
      discount of the current trading price at the time of issue. The payments shall
      be made payable to Atlantic Television Marketing, Inc. in accordance with the
      following schedule:

     

    $10,500.00
      -- upon execution of this agreement.

    $10,500.00
      -- due 30 days from execution of this agreement.

    $10,500.00
      -- due 60 days from the execution of this agreement.

     

    In
      addition, as part of its compensation for services, Atlantic shall receive
      a
      royalty on all sales of the Product and companion products sold in conjunction
      with the campaign.

     

    The
      royalties shall be paid quarterly (within 21 business days of the close of
      the
      previous quarter’s sales activity) and shall be calculated as
      follows:

     

    1.  For
      all
      sales of the Product generated from direct sales through any form of media
      including news media, advertising, and the internet, Genotec will pay to
      Atlantic 2% of the Total Package selling price, inclusive of any additional
      products sold as upsells to consumers.

     

    2.  For
      all
      sales of the Product generated from catalogue distribution, print syndication,
      and credit card syndication, Genotec will pay to Atlantic 2% of the net
      wholesale selling price received by Genotec for this category.

     

    3.  For
      all
      sales generated from home shopping outlets (ie: HSN, QVC) for all Products,
      Genotec will pay to Atlantic 2% of the net wholesale selling price received
      by
      Genotec for this category.

     

    4.  For
      all
      sales generated from retail distribution of the Product, Genotec will pay to
      Atlantic 2% of the net wholesale selling price.

     

    Atlantic
      shall have the right, with advance notice of 30 days and at its own expense,
      to
      audit all sales and activity reports related to the campaign and any additional
      projects that may be developed under an extension of this
      agreement.

     

    TERM

     

    This
      agreement shall commence on the date of execution and terminate 90 days from
      the
      date of execution unless otherwise extended and amended in writing. Upon
      termination of this agreement, Atlantic shall continue to receive royalties
      on
      the Product as outlined herein for a period of twelve (12) months following
      the
      termination.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    OWNERSHIP
      AND INDEMNITY

     

    It
      is
      understood that Genotec, is the client of Atlantic and Atlantic acknowledges
      that its services hereunder shall be deemed as “works made for hire” as that
      term is understood in federal copyright law. Accordingly, all right, title
      and
      interest, in, to, or derived from (or ancillary to) the marketing campaign
      and
      any work product, customer list, and other materials created or generated by
      Atlantic or its employees, vendors and agents in the course of or related to
      Atlantic’s engagement hereunder shall be and remain the exclusive property of
      Genotec and shall not be used, distributed, or re-sold by Atlantic, any service
      providers, or any other parties without prior written consent of
      Genotec.

     

    As
      part
      of this agreement, Genotec agrees to defend, indemnify, and hold Atlantic
      Television Marketing its officers, directors, employees, affiliates, agents,
      and
      assigns harmless from and against any and all proceedings, actions, suits,
      costs
      (including reasonable attorney’s fees and court costs), expenses, damages and/or
      other liabilities arising out of or in connection with the services provided
      to
      Genotec or the marketing of Genotec’s Product in any manner or form, or any and
      all challenges or claims which may be made by any state, federal or local
      governmental or regulatory authority or any third party with respect to
      challenges to the authenticity, accuracy or verification of any Product
      attributes or claims provided.

     

    Genotec
      acknowledges and represents that all warrantees and liability coverage with
      respect to the Product shall include Atlantic Television Marketing, Inc. as
      an
      additionally named insured party and will also run to the end user of said
      Products. Without limiting sections above, Genotec shall also protect, defend,
      indemnify and save Atlantic harmless from any and all proceedings, actions,
      suits, claims, demands, loss, costs, damages, and expenses (including reasonable
      attorney’s fees and court costs) whatsoever arising out of or relating to any
      claims from said end user of the Product. The obligation of Genotec to indemnify
      Atlantic shall survive the execution and delivery of this Agreement and the
      termination of this Agreement for any reason whatsoever.

     

    This
      Agreement shall be construed in accordance with and governed by the laws of
      the
      State of New York without regard to its applicable conflict of law rules. Any
      controversy or claim arising out of or relating to this Agreement or its breach
      shall be settled by binding arbitration in accordance with the then governing
      rules of the American Arbitration Association with a panel consisting of one
      arbitrator unless that number be increased by consent of both parties. Judgment
      upon the award rendered may be entered and arbitration proceedings shall be
      in
      the State of New York.

     

     

    
 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    This
      document represents the entire agreement between Atlantic Television Marketing,
      Inc. and Genotec Nutritionals, Inc. and can only be changed, altered, or
      superseded with the written approval of both parties.

     

    Accepted
      and Approved By:

     

    ________________________________________

    William
      J. Maier

    President

    Atlantic
      Television Marketing, Inc. 

    199
      Main Street, Suite 300 

    Northport,
      New York 11768

    (631)
      261-4600

    

    Accepted
      and Approved By:

    

    
      	
              ______________________________________________

            	
                       
                ___________________________________

            
	
              Mark
                Meller

              Genotec
                Nutritionals, Inc. 

              (address)

            	
              DateExhibit 10.31 Amended Agreement

    
      

    

     

                                                                                                    Exhibit
      10.31

     

     

    

    AMENDMENT
      NUMBER 1 TO 

    AMENDED
      AND RESTATED SECURITIES PURCHASE AGREEMENT

    

    

     THIS
      AMENDMENT AGREEMENT (the
      “Amendment”) is
      entered into as of January ____, 2007, between MM2
      GROUP, INC., a
      corporation organized and existing under the laws of the State of New Jersey
      (the “Company”),
      and
CORNELL
      CAPITAL PARTNERS, LP a
      Delaware limited partnership (the
      “Investor”).

    

    WHEREAS,
      the
      Company and the Investor are parties to a certain Amended and Restated
      Securities Purchase Agreement dated as of July 20, 2006 (the “Agreement”);
      and

     

    WHEREAS,
      the
      parties wish to amend the Agreement as set forth below. 

     

    NOW,
      THEREFORE,
      it is
      agreed: 

     

    I.     
      Amendments.

     

    A.    AMENDMENT
      OF THE 6th“WHEREAS”
      CLAUSE.
      The
      sixth (6th)
      “WHEREAS” Clause of the Agreement is hereby deleted in its entirety and the
      following language shall replace said section of the Agreement:

     

    WHEREAS,
      the
      parties desire that, upon the terms and subject to the conditions contained
      herein, the Company shall issue and sell to the Buyer(s), as provided herein,
      and the Buyer(s) shall purchase up to Two Million Five Hundred Thousand Dollars
      ($2,500,000) of secured convertible debentures (the “Convertible
      Debentures”),
      which
      shall be convertible into shares of the Company’s Class A common stock, no par
      value per share (the “Common
      Stock”)
      (as
      converted, the “Conversion
      Shares”)
      of
      which One Million Two Hundred Fifty Thousand Dollars ($1,250,000) was previously
      funded pursuant to the secured convertible debenture issued by the Company
      to
      the Investor on or about April 1, 2005, which has been amended and restated
      on
      July 20, 2006 to reflect the Assignment and Assumption Agreement and accrued
      but
      unpaid interest (the “First
      Closing”)
      and
      Six Hundred Twenty-Five Thousand Dollars ($625,000) shall be funded two (2)
      business days prior to the date the Registration Statement (the “Registration
      Statement”)
      is
      filed with the SEC (the “Second
      Closing”),
      and
      Six Hundred Twenty-Five Thousand Dollars ($625,000) shall be funded two (2)
      business days prior to the date the Registration Statement is declared effective
      by the SEC (the “Third
      Closing”)
      (individually referred to as a “Closing”
      collectively referred to as the “Closings”),
      for a
      total purchase price of up to Two Million Five Hundred Thousand Dollars
      ($2,500,000), (the “Purchase
      Price”)
      in the
      respective amounts set forth opposite each Buyer(s) name on Schedule I (the
      “Subscription
      Amount”);

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

     

    B.    AMENDMENT
      TO SECTION 1(b).
      Section
      1(b) of the Agreement is hereby deleted in its entirety and the following
      language shall replace said Section 1(b) of the Agreement:

     

    Section
      1(b): Closing
      Date. The
      First
      Closing of the purchase and sale of the Convertible Debentures previously took
      place on or about April 1, 2005 (the “First
      Closing Date”).
      The
      Second Closing of the purchase and sale of the Convertible Debentures shall
      take
      place at 10:00 a.m. Eastern Standard Time two (2) business days prior to the
      date the Registration Statement is filed with the SEC, subject to notification
      of satisfaction of the conditions to the Second Closing set forth herein and
      in
      Sections 6 and 7 below (or such later date as is mutually agreed to by the
      Company and the Buyer(s)) (the “Second
      Closing Date”),
      and
      the Third Closing of the purchase and sale of the Convertible Debentures shall
      take place at 10:00 a.m. Eastern Standard Time two (2) business days prior
      to
      the date the Registration Statement is declared effective by the SEC, subject
      to
      notification of satisfaction of the conditions to the Third Closing set forth
      herein and in Sections 6 and 7 below (or such later date as is mutually agreed
      to by the Company and the Buyer(s)) (the “Third
      Closing Date”)
      (collectively referred to a the “Closing
      Dates”).
      The
      Closings shall occur on the respective Closing Dates at the offices of Yorkville
      Advisors, LLC, 101 Hudson Street, Suite 3700, Jersey City, New Jersey 07302
      (or
      such other place as is mutually agreed to by the Company and the
      Buyer(s)).

     

    C.    AMENDMENT
      TO SECTION 7.
      Section
      7 of the Agreement is hereby deleted in its entirety and the following language
      shall replace said Section 7 of the Agreement:

     

     Section
      7:    CONDITIONS
      TO THE BUYER’S OBLIGATION TO PURCHASE.

    

    (a)
       The
      obligation of the Buyer(s) hereunder to accept the Convertible Debentures at
      the
      Second Closing is subject to the satisfaction, at or before the Second Closing
      Date, of each of the following conditions:

     

    (i) The
      Common Stock shall be authorized for quotation on the OTCBB, and trading in
      the
      Common Stock shall not have been suspended for any reason. 

     

    (ii) The
      representations and warranties of the Company shall be true and correct in
      all
      material respects (except to the extent that any of such representations and
      warranties is already qualified as to materiality in Section 3 above, in which
      case, such representations and warranties shall be true and correct without
      further qualification) as of the date when made and as of the Second Closing
      Date as though made at that time (except for representations and warranties
      that
      speak as of a specific date) and the Company shall have performed, satisfied
      and
      complied in all material respects with the covenants, agreements and conditions
      required by this Agreement to be performed, satisfied or complied with by the
      Company at or prior to the Second Closing Date. 

     

     

    
      
        2

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (iii)    The
      Company shall have executed and delivered to the Buyer(s) the Convertible
      Debentures in the respective amounts set forth opposite each Buyer(s) name
      on
      Schedule I attached hereto.

     

    (iv)    The
      Company shall file the registration statement with the SEC in compliance with
      the rules and regulations promulgated by the SEC for filing thereof within
      two
      (2) days of the Second Closing Date. 

     

    (v)    The
      Company shall have certified, in a certificate executed by two officers of
      the
      Company and dated as of the Second Closing Date, that all conditions to the
      Second Closing have been satisfied.

     

    (b)     The
      obligation of the Buyer(s) hereunder to accept the Convertible Debentures at
      the
      Third Closing is subject to the satisfaction, at or before the Second Closing
      Date, of each of the following conditions:

    

    (i)    The
      Common Stock shall be authorized for quotation on the OTCBB, and trading in
      the
      Common Stock shall not have been suspended for any reason. 

    

    (ii)    The
      representations and warranties of the Company shall be true and correct in
      all
      material respects (except to the extent that any of such representations and
      warranties is already qualified as to materiality in Section 3 above, in which
      case, such representations and warranties shall be true and correct without
      further qualification) as of the date when made and as of the Second Closing
      Date as though made at that time (except for representations and warranties
      that
      speak as of a specific date) and the Company shall have performed, satisfied
      and
      complied in all material respects with the covenants, agreements and conditions
      required by this Agreement to be performed, satisfied or complied with by the
      Company at or prior to the Third Closing Date. 

     

    (iii)    The
      Company shall have executed and delivered to the Buyer(s) the Convertible
      Debentures in the respective amounts set forth opposite each Buyer(s) name
      on
      Schedule I attached hereto.

     

    (iv)    The
      Registration Statement shall be declared effective by the SEC within two (2)
      days of the Third Closing Date. 

     

    (v)    The
      Company shall have certified, in a certificate executed by two officers of
      the
      Company and dated as of the Third Closing Date, that all conditions to the
      Third
      Closing have been satisfied.

     

    II. Miscellaneous.

    

    
      	 	
              A.

            	
              Except
                as provided hereinabove, all of the terms and conditions contained
                in the
                Agreement shall remain unchanged and in full force and
                effect.

            

    

     

     

    
      
        3

      

      
        
        

        
          

        

      

      
        
        

      

       

       

    

    
      	 	
              B.

            	
              This
                Amendment is made pursuant to and in accordance with the terms and
                conditions of the Agreement.

            

    

    

    
      	 	
              C.

            	
              All
                capitalized but not defined terms used herein shall have those meanings
                ascribed to them in the Agreement.

            

    

    

    D. All
      provisions in the Agreement and any amendments, schedules or exhibits thereto
      in
      conflict with this Amendment shall be and hereby are changed to conform to
      this
      Amendment.

     

    [REMAINDER
      OF THIS PAGE INTENTIONALLY LEFT BLANK]

     

     

     

     

    
      
        4

        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF,
      the
      parties hereto have caused this Amendment to be executed by the undersigned,
      thereunto duly authorized, as of the date first set forth above.

     

    

    
      	 	
              COMPANY:

            
	 	
              MM2
                GROUP, INC. 

            
	 	 
	 	
              By: ________________________

            
	 	
              Name Mark
                Meller

            
	 	
              Title: President
                & CEO

            
	 	 
	 	 
	 	
              CORNELL
                CAPITAL PARTNERS, LP

            
	 	
              By:
                Yorkville Advisors LLC

            
	 	
              Its:
                General Partner

            
	 	 
	 	
              By: ________________________

            
	 	
              Name Mark
                Angelo

            
	 	
              Title: Portfolio
                Manager

            
	 	 

    

     

    
 

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]